Evidence map›Paper›PMID 33897173›Full record

ArticleUrology annals

Ureteral carcinoma metastasizing to the testicle: Can misdiagnosis of orchiepididymitis be avoided?

Ioanna Gazouli, Stavros Tsampalas, Ioannis Tsimaris, Georgios Zarkavelis, Nikolaos Grivas, Eleftherios Kampletsas, Alexandra Papadaki, Leonidas Mavroeidis, Panagiotis Ntellas, Stefania Gkoura and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Urology annals. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Ioanna GazouliDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Stavros TsampalasDepartment of Urology, University Hospital of Ioannina, Ioannina, Greece.
Ioannis TsimarisDepartment of Urology, Chatzikosta General Hospital, Ioannina, Greece.
Georgios ZarkavelisDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Nikolaos GrivasDepartment of Urology, Chatzikosta General Hospital, Ioannina, Greece.
Eleftherios KampletsasDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Alexandra PapadakiDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Leonidas MavroeidisDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Panagiotis NtellasDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Stefania GkouraDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Lampriani TsaliPACMeR Athens, PanHellenic Association for Continual Medical Research, Ioannina, Greece.
Anna-Lea AmylidiDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Maria Smaragdi VlachouMedical School, University of Ioannina, Ioannina, Greece.
Davide MauriDepartment of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Hellenic Society for the Study of Bone Metabolism · GRUniversity Hospital of Ioannina · GRGeneral Hospital of Ioannina G. Hatzikosta · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testicular metastases from ureteral carcinoma are rare and they are generally mimic orchiepididymitis. For this reason, these are associated to misleading diagnoses and cancer treatment delay. We believe that both timing and knowledge of genital blood and lymph reverse flow routes may represent two important parameters for avoiding misleading diagnoses and speed proper anticancer treatment. We describe a case and discuss pathophysiological data and relevant literature.

Indexed as

Metastasisorchiepididymitistesticularupper tract urothelial carcinomauretervas deferens

Identifiers

PMID33897173
PMCPMC8052902
OpenAlexW3123768616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.